European equities traded in the US as American depositary receipts were moving lower late Friday morning, declining 0.85% to 1,302.64 on the S&P Europe Select ADR Index, which is down about 2.8% for the week.
From continental Europe, the gainers were led by financial services company Banco Bilbao Vizcaya Argentaria (BBVA) and pharmaceutical company Ascendis Pharma (ASND), which rose 3.2% and 2.7%, respectively. They were followed by biopharmaceutical company DBV Technologies (DBVT) and financial services company Banco Santander (SAN), which increased 2.3% and 2.2%, respectively.
The decliners from continental Europe were led by biotech firm Evaxion Biotech (EVAX) and biopharmaceutical company Cellectis (CLLS), which fell 9.3% and 6.8%, respectively. They were followed by biotech firm BioNTech (BNTX) and biopharmaceutical company argenx (ARGX), which lost 6.2% and 4.5%, respectively.
From the UK and Ireland, the gainers were led by biopharmaceutical company TC Biopharm (TCBP) and financial services company Lloyds Banking Group (LYG), which advanced 16% and 2%, respectively. They were followed by tobacco company British American Tobacco (BTI) and insurance company Prudential (PUK), which were up 1.9% and 1.5%, respectively.
The decliners from the UK and Ireland were led by biopharmaceutical companies Akari Therapeutics (AKTX) and Biodexa Pharmaceuticals (BDRX), which tumbled 20% and 12%, respectively. They were followed by biopharmaceutical companies Mereo BioPharma Group (MREO) and Bicycle Therapeutics (BCYC), which dropped 5.7% and 5.5%, respectively.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。